The CMS is waiving an Obama-era guidance that prohibited Medicare Advantage plans from imposing prior authorization requirements on Part B drugs.
The CMS is waiving an Obama-era guidance that prohibited Medicare Advantage plans from imposing prior authorization requirements on Part B drugs.